P650: Next generation sequencing for pediatric cancer predisposition: Analytical performance of a 137-gene panel
Abstract
Cancer predisposition syndromes (CPS), identified through germline genetic testing, account for approximately 7-15% of pediatric cancer diagnoses. This study aimed to develop and validate a next generation sequencing (NGS) panel for the detection of germline variants in genes associated with pediatric solid tumors and CPS.
Fields of Study & Subjects
BRCA gene mutations in cancer
Genomics and Rare Diseases
Cancer Genomics and Diagnostics
Publication details
- Journal / source
- Genetics in Medicine Open
- Volume
- 4
- Pages
- 104140–104140
- Publication date
- 1 January 2026
- Language
- EN